Targeting sphingosine kinase 2 for the treatment of multiple myeloma
Clinical Trial Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
August 3, 2015
End Date
July 31, 2021
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
August 3, 2015
End Date
July 31, 2021